Apr 2025

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

Zimerman A, Kunzler ALF, Weber BN, et al.

First published: April 21, 2025  DOI: 10.1161/CIRCULATIONAHA.124.072756